The significance of the study.
As it proved, our information to change people’s goals had no impact – – but we still discovered that the wristbands reduce nausea symptoms.’ The study involved 88 people divided into three groups. All of the participants were experiencing some degree of nausea after receiving at least two radiation remedies for numerous kinds of cancer. Dr. Roscoe described that while chemotherapy is more linked with generating nausea and vomiting frequently, radiation to the digestive tract could cause those distressing symptoms also.Keryx can be Aeterna Zentaris’ partner and licensee for perifosine in the United States, Canada and Mexico. Related StoriesNew antenna-like device makes breast cancer surgery much easier for surgeonsViralytics enters into clinical trial collaboration contract with MSDSausages With Antioxidants From Berries TO AVOID CancerJuergen Engel, Ph.D., CEO and President of Aeterna Zentaris stated, The orphan-drug designation in neuroblastoma is another important milestone in the development of perifosine simply because a novel method of treating cancer patients, particularly in this region of unmet medical want. We are looking towards perifosine’s future development in neuroblastoma and in additional indications with our partner Keryx. Phase 1 data of perifosine in recurrent pediatric solid tumors, including neuroblastoma, were provided last month in the pediatric solid tumor poster discussion program held at the 46th Annual Interacting with of the American Culture of Clinical Oncology .